75 related articles for article (PubMed ID: 26427968)
1. Evaluation of the efficacy and safety of propranolol, timolol maleate, and the combination of the two, in the treatment of superficial infantile haemangiomas.
Gong H; Xu DP; Li YX; Cheng C; Li G; Wang XK
Br J Oral Maxillofac Surg; 2015 Nov; 53(9):836-40. PubMed ID: 26427968
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Introduction Timolol Maleate by Manometer Microneedles among Infantile Hemangioma: A Retrospective Study in China.
Yuan L; Wang J
Eur J Pediatr Surg; 2024 Jun; 34(3):261-266. PubMed ID: 37127023
[TBL] [Abstract][Full Text] [Related]
3. Infantile Sacral Region Hemangioma and Combination Treatment with Propranolol and Topical Timolol: Case Review and Reference Review.
Kardasevic M; Dinarevic SM
Med Arch; 2021 Apr; 75(2):158-161. PubMed ID: 34219878
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of topical brimonidine-timolol for haemangioma of infancy and perils of off-label prescribing.
Chu MB; Searcy G; Siegfried E
BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23598940
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of timolol in the treatment of facial hemangioma and its effect on the proliferation and apoptosis of hemangioma stem cells.
Zhu H; Luo H; Lai W
Cell Mol Biol (Noisy-le-grand); 2023 Oct; 69(10):115-120. PubMed ID: 37953576
[TBL] [Abstract][Full Text] [Related]
6. Cardiac side effects of propranolol in infants treated for infantile haemangiomas.
Maliqari N; Duka E; Kuneshka L
Cardiol Young; 2023 Dec; 33(12):2616-2620. PubMed ID: 37078179
[TBL] [Abstract][Full Text] [Related]
7. Beta-blockers for the treatment of infantile haemangiomas in premature infants.
Ling LCT; Aan MKJ
Australas J Dermatol; 2024 Jun; ():. PubMed ID: 38923498
[TBL] [Abstract][Full Text] [Related]
8. Reply to 'Comment on 'The effectiveness and safety of topical beta-receptor blocker in treating superficial infantile haemangiomas: A meta-analysis including 20 studies' Dr. Sun et al.'.
Lin Z
Br J Clin Pharmacol; 2022 Jun; 88(6):3002-3003. PubMed ID: 35118695
[No Abstract] [Full Text] [Related]
9. Evaluation of intralesional propranolol for periocular capillary hemangioma.
Awadein A; Fakhry MA
Clin Ophthalmol; 2011; 5():1135-40. PubMed ID: 21887095
[TBL] [Abstract][Full Text] [Related]
10. Treatment patterns and outcomes in children with infantile hemangiomas: A retrospective observational analysis.
Cai Y; Ge Y; Ung COL; Li F; Wang J; Xia C; Hu H
SAGE Open Med; 2021; 9():20503121211056844. PubMed ID: 34938569
[TBL] [Abstract][Full Text] [Related]
11. Use of propranolol in infantile haemangiomas: report of five cases and review of the literature.
Gidaris D; Economou M; Hatzidemetriou V; Gombakis N; Athanassiou-Metaxa M
Hippokratia; 2011 Jan; 15(1):81-3. PubMed ID: 21607042
[TBL] [Abstract][Full Text] [Related]
12. Association of Attention Deficit Hyperactivity Disorder with the Use of Oral Propranolol in Infantile Haemangiomas: An Ambispective Comparative Study.
Sharma A; Venkatesan V; Sharma A; Ashraf R; De D; Handa S; Mahajan R
Indian J Dermatol; 2024; 69(2):171-173. PubMed ID: 38841227
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of propranolol in 55 cases of infantile periocular hemangioma.
Song D; Li Y; Wang L; Liu G
Asian J Surg; 2024 Apr; ():. PubMed ID: 38599964
[No Abstract] [Full Text] [Related]
14. Topical Timolol as a Therapeutic Modality in Severe Disfiguring Infantile Haemangioma.
Mahajan M; Mahajan BB
Indian J Dermatol; 2024; 69(1):99-100. PubMed ID: 38572057
[No Abstract] [Full Text] [Related]
15. Topical Timolol Vs. Oral Propranolol for the Treatment of Superficial Infantile Hemangiomas.
Wu HW; Wang X; Zhang L; Zheng JW; Liu C; Wang YA
Front Oncol; 2018; 8():605. PubMed ID: 30619747
[No Abstract] [Full Text] [Related]
16. Interventions for infantile haemangiomas of the skin.
Novoa M; Baselga E; Beltran S; Giraldo L; Shahbaz A; Pardo-Hernandez H; Arevalo-Rodriguez I
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD006545. PubMed ID: 29667726
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Efficacy and Safety Between Propranolol and Steroid for Infantile Hemangioma: A Randomized Clinical Trial.
Kim KH; Choi TH; Choi Y; Park YW; Hong KY; Kim DY; Choe YS; Lee H; Cheon JE; Park JB; Park KD; Kang HJ; Shin HY; Jeong JH
JAMA Dermatol; 2017 Jun; 153(6):529-536. PubMed ID: 28423174
[TBL] [Abstract][Full Text] [Related]
18. The Efficacy and Safety of Topical β-Blockers in Treating Infantile Hemangiomas: A Meta-Analysis Including 11 Randomized Controlled Trials.
Wang X; Feng W; Zhao X; Liu Z; Dong L
Dermatology; 2021; 237(3):433-443. PubMed ID: 33027794
[TBL] [Abstract][Full Text] [Related]
19. Effect of topical timolol on response rate and adverse events in infantile hemangioma: a meta-analysis.
Zheng L; Li Y
Arch Dermatol Res; 2018 May; 310(4):261-269. PubMed ID: 29362868
[TBL] [Abstract][Full Text] [Related]
20. Combined Oral and Topical Beta Blockers for the Treatment of Early Proliferative Superficial Periocular Infantile Capillary Hemangioma.
Marey HM; Elmazar HF; Mandour SS; Khairy HA
J Pediatr Ophthalmol Strabismus; 2018 Jan; 55(1):37-42. PubMed ID: 28991344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
